Aardvark Adventures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures

DAVE 212.78

+1.3%

12:55 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ~digs who wrote (2243)	8/17/2006 3:31:39 AM
From: ~digs	Read Replies (1) of 7944

WEDX 3.5 CALGARY, Aug. 9 /PRNewswire-FirstCall/ - The Westaim Corporation announced today that for the second quarter ended June 30, 2006, it recorded a net loss of $12.0 million or 13 cents per share, on revenues of $7.0 million. In the same quarter last year, the company recorded a net loss of $10.2 million, or 11 cents per share, on revenues of $5.7 million. "We have made important advancements at both iFire Technology and NUCRYST Pharmaceuticals in the first half of 2006," said Barry M. Heck, President and CEO of Westaim. "iFire continues to generate positive results from its pilot manufacturing facility and is moving towards engineering samples of its TDEL flat panel displays. NUCRYST's second Phase 2 clinical trial is well underway for a topical cream formulation of its nanocrystalline silver and they remain on target to release results before year end." biz.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next